Emil M deGoma MD

Adult Congenital Heart Disease, Preventive Cardiology

Medical Director, Preventive Cardiology, Perelman School of Medicine at University of Pennsylvania

3400 Civic Center Blvd# AstPhiladelphia, PA 19104
Phone+1 215-615-4949
Fax+1 215-614-0069

Dr. deGoma is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. deGoma's full profile Already have an account?

Education & Training

Hospital of the University of PennsylvaniaPost-Doctoral Fellowship, 2010 - 2011
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2007 - 2010
Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2006 - 2007
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2004 - 2006
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2003 - 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2017 - 2027
PA State Medical License 2010 - 2026
CA State Medical License 2004 - 2011
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016

Clinical Trials

Assessment Of Vascular Health After Niacin Therapy (AVANT)
COMPLETED
NA
Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
COMPLETED
PHASE2

Publications & Presentations

PubMed

2 citations
Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm.
Stephen Burgess, Héléne T Cronjé, Emil deGoma, Yung Chyung, Dipender Gill
Arteriosclerosis, Thrombosis, and Vascular Biology. 2025-02-01
85 citations
IL-6 and Cardiovascular Risk: A Narrative Review.
Nehal N Mehta, Emil deGoma, Michael D Shapiro
Current Atherosclerosis Reports. 2024-11-26
41 citations
Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese...
Masaomi Nangaku, Youssef M.K. Farag, Emil M. deGoma, Wenli Luo, Dennis Vargo
Nephrology, Dialysis, Transplantation. 2021-06-28

Journal Articles

Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis.
deGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ, Atherosclerosis 2012;224:274-9
Targeting high density lipoproteins in the prevention of cardiovascular disease.
Larach D, deGoma EM, Rader DJ, Curr Cardiol Rep
Approach to the Patient with Extremely Low HDL- Cholesterol.
Rader DJ, deGoma EM, J Clin Endocrinol Metab 2012;97:3399-407

Books/Book Chapters

Comprehensive Management of High Risk Cardiovascular Patients.
Chapter: Peripheral arterial disease
deGoma EM, Rockson SGEditors: Toth PP, Gotto AM, Jr.Informa Healthcare, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Penetrating Atherosclerotic Ulcer and Intramural Hematoma
deGoma EM, Moulik S, Rovno SEditors: ER Mohler III.Demos Medical Publishing, New York
Atlas of Vascular Medicine: A Case-Based Approach to Current Management.
Chapter: Type A Acute Aortic Dissection
Shiran H, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York

Abstracts/Posters

Clinical significance of HDL-C levels among patients with LDL-C < 60 mg/dL.
deGoma EM, Leeper NJ, Heidenreich PA, AHA Scientific Sessions
Statin use in patients with low LDL-C is associated with improved survival.
Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA, AHA Scientific Sessions

Lectures

Subclinical atherosclerosis imaging.
Perelman School of Medicine at the University of Pennsylvania. Cardiology Grand Rounds. Philadelphia
Coronary artery calcium scanning for cardiovascular risk refinement.
Perelman School of Medicine at the University of Pennsylvania. Medicine Grand Rounds. Philadelphia

Press Mentions

Cardiologist Named Chief Medical Officer of Biotech CompanyMarch 26th, 2026
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. RidkerJanuary 10th, 2025
New Review Finds Statin Use Not Linked to a Decline in Cognitive FunctionFebruary 10th, 2016